Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Emmert Roberts

2022–23 U.K. Harkness Fellow; Clinical Research Fellow at the National Addiction Centre, King’s College London (KCL); Practicing Addiction Psychiatrist at the South London and the Maudsley NHS Foundation Trust

Headshot of Emmert Roberts

Placement: Stanford University

Mentor: Keith Humphreys, Ph.D., Esther Ting Memorial Professor, Stanford Health Policy Associate, Stanford School of Medicine

Project: Mortality Due to Opioid Overdose Among Individuals Minoritized on the Basis of Sex, Gender Identity, and Sexual Orientation: Prevalence, Policy and Practice

Emmert Roberts, M.A., M.Sc., BMBCh, Ph.D., MRCP, MRCPsych, is a 2022–23 U.K. Harkness Fellow in Health Care Policy and Practice. He is a clinical research fellow at the National Addiction Centre, King’s College London (KCL) and a practicing addiction psychiatrist at the South London and the Maudsley NHS Foundation Trust. Roberts is a member of both the Royal Colleges of Physicians and Psychiatrists, and an honorary analyst at the Office of Health Improvement and Disparities within the U.K. government Department of Health and Social Care. His research focuses on drug and alcohol service provision for marginalized populations and its relationship with overdose related mortality. He holds current research grants from the Medical Research Council and the National Institute of Health Research. Roberts graduated with distinctions in medicine from the University of Oxford and epidemiology from the London School of Hygiene and Tropical Medicine and holds a Ph.D. in addiction sciences from KCL.

Project Overview: In 2020 both the U.S. and the U.K. reported their highest number of opioid overdose deaths since records began. Research from both countries consistently demonstrates disproportionate opioid-related harms in specific sociodemographically minoritized groups.

The overall aim of this project is to estimate current rates of opioid overdose-related mortality and determine if there are any significant differences among individuals on the basis of sex, gender identity, or sexual orientation. In groups with significantly elevated rates, we aim to explore what policies or practice models, if any, currently exist to target or prioritize treatment for problematic opioid use to individuals identified as higher risk, and what factors may affect their implementation and effectiveness.